Image Place holder

Darcy Berry,

 
Specialty: Genetics
Program:

Overview

Darcy Berry, MS, CGC is a native Floridian and a certified genetic counselor in the Genetics Risk Assessment Clinic at Moffitt Cancer Center. She earned her Bachelor of Science degree at Miami University of Ohio in 2011 with a minor in Neuroscience and a European Culture & Society Concentration. She then completed her Master of Science in Genetic Counseling at the University of South Carolina in 2013. Darcy gained employment at Navicent Health in Macon, Georgia in 2013 and earned her certification from the American Board of Genetic Counseling in 2014. She was the sole clinician at the cancer genetic counseling clinic for nearly five years in Macon, GA before joining the team at Moffitt in the fall of 2018. She was excited to return home to Florida and to work with the brilliant minds at Moffitt and USF to advance the field of genetic counseling and improve the lives of those affected by hereditary cancer.  While at Moffitt, she has enjoyed her role as an Affiliate Assistant Professor at USF’s College of Public Health, teaching hereditary cancer lectures for the genetic counseling students and serving as a rotation supervisor. Darcy is the current treasurer of the Florida Association of Genetic Counselors (FLAGC) and was previously elected as co-chair of the Georgia Cancer Genetics Network (GCGN). In 2021, she is looking forward to contributing to launching Florida’s first hereditary pediatric cancer clinic with Moffitt’s new pediatric hematologist/ oncologist, Dr. Colin Moore. Darcy is passionate about patient care and optimistic about how genetic testing will be able to improve the care of Moffitt’s patients. 


Education & Training

Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • McDonald J, Chuang CY, Hicks JK, Berry DK, Imanirad I, Rishi A, Frakes JM, Hoffe SE, Felder S. FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation. Adv Radiat Oncol. 2021 May.6(5):100717. Pubmedid: 34258475. Pmcid: PMC8260782.
  • Berry DK, Wang X, Michalski ST, Kang HC, Yang S, Creelan BC, McLeod HL, Hicks JK. Clinical Cohort Analysis of Germline EGFR T790M Demonstrates Penetrance Across Ethnicities and Races, Sexes, and Ages. JCO Precis Oncol. 2020 Mar.4. Pubmedid: 34164592. Pmcid: PMC8216676.

Patient Comments
Overall Satisfaction

patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments